Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit
-
- STATUS
- Not Recruiting
-
- participants needed
- 10
-
- sponsor
- University Hospital, Akershus
Updated on 22 July 2024
Summary
An open, observational health economic study to estimate marginal cost and health consequences of replacing conventional Parkinsons disease therapy with intraduodenal levodopa administered continuously
Details
| Condition | Parkinson Disease |
|---|---|
| Treatment | Levodopa (drug), intraduodenal administration |
| Clinical Study Identifier | NCT00272688 |
| Sponsor | University Hospital, Akershus |
| Last Modified on | 22 July 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.